# Clinical Analgesic Management in Dementia

> **NCT07323914** · PHASE3 · RECRUITING · sponsor: **Xuanwu Hospital, Beijing** · enrollment: 10 (estimated)

## Conditions studied

- Alzheimer Disease

## Interventions

- **DRUG:** Tylex

## Key facts

- **NCT ID:** NCT07323914
- **Lead sponsor:** Xuanwu Hospital, Beijing
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-01
- **Primary completion:** 2027-01-01
- **Final completion:** 2027-03-31
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07323914

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07323914, "Clinical Analgesic Management in Dementia". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07323914. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*